These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15552394)

  • 21. Establishing pan-European clinical trials: regulatory compliance and other practical considerations.
    Grienenberger A
    J Biolaw Bus; 2004; 7(4):58-63. PubMed ID: 15675097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulatory impediments jeopardizing the conduct of clinical trials in Europe funded by the National Institutes of Health.
    Neaton JD; Babiker A; Bohnhorst M; Darbyshire J; Denning E; Frishman A; Grarup J; Larson G; Lundgren J
    Clin Trials; 2010 Dec; 7(6):705-18. PubMed ID: 20729252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Re-engineering the European Union Clinical Trials Directive.
    Kenter MJ; Cohen AF
    Lancet; 2012 May; 379(9828):1765-7. PubMed ID: 22579309
    [No Abstract]   [Full Text] [Related]  

  • 24. [Drugs in the European Union: the health-market complex].
    Antoñanzas F; Rodríguez R; Sacristán JA; Illa R
    Gac Sanit; 2005; 19(2):151-67. PubMed ID: 15860163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast cancer research and the European Union Clinical Trials Directive.
    Williams N
    Breast Cancer Res; 2004; 6(4):145-7. PubMed ID: 15217484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Fundamental principles of clinical trials].
    Skarke C; Geisslinger G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Apr; 48(4):401-7. PubMed ID: 15830250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The unintended consequences of clinical trials regulations.
    McMahon AD; Conway DI; Macdonald TM; McInnes GT
    PLoS Med; 2009 Nov; 3(11):e1000131. PubMed ID: 19918557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical research law in Jordan.
    Treish IM
    Dev World Bioeth; 2009 Aug; 9(2):97. PubMed ID: 19645717
    [No Abstract]   [Full Text] [Related]  

  • 29. The International Conference on Harmonization common technical document--global submission format?
    Molzon JA
    Food Drug Law J; 2005; 60(3):447-51. PubMed ID: 16304749
    [No Abstract]   [Full Text] [Related]  

  • 30. Evaluation of clinical trials by Ethics Committees in Germany: experience of applicants with the review of requests for opinion of the Ethics Committees - results of a survey among members of the German Association of Research-Based Pharmaceutical Companies (VFA).
    Russ H; Busta S; Riedel A; Zöllner G; Jost B
    Ger Med Sci; 2009 Jul; 7():Doc07. PubMed ID: 19675747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Policy making on data exclusivity in the European Union: from industrial interests to legal realities.
    Adamini S; Maarse H; Versluis E; Light DW
    J Health Polit Policy Law; 2009 Dec; 34(6):979-1010. PubMed ID: 20018988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulating the market in human research participants.
    Lemmens T; Miller PB
    PLoS Med; 2006 Aug; 3(8):e330. PubMed ID: 16866575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging trends in contract research industry in India.
    Drabu S; Gupta A; Bhadauria A
    Contemp Clin Trials; 2010 Sep; 31(5):419-22. PubMed ID: 20609394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New regulatory rules for clinical trials in the United States and the European Union: key points and comparisons.
    Miossec M; Miossec P
    Arthritis Rheum; 2006 Dec; 54(12):3735-40. PubMed ID: 17133535
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug companies should release data from all trials of licensed drugs, say MPs.
    Hawkes N
    BMJ; 2013 Jan; 346():f321. PubMed ID: 23325880
    [No Abstract]   [Full Text] [Related]  

  • 36. Ethics-committee authorization in Germany.
    Graf HP; Cole D
    J Med Ethics; 1995 Aug; 21(4):229-33. PubMed ID: 7473643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Throwing a wrench in the works?
    Meunier F; Dubois N; Negrouk A; Rea LA; Saghatchian M; Tursz T; Sullivan R; Law K; Tiner R
    Lancet Oncol; 2003 Dec; 4(12):717-9. PubMed ID: 14662426
    [No Abstract]   [Full Text] [Related]  

  • 38. European Clinical Trials Directive: responses made to MHRA consultation letter MLX 287.
    Flavell DJ; Flavell SU; Sullivan R
    Lancet; 2003 Oct; 362(9393):1415. PubMed ID: 14585646
    [No Abstract]   [Full Text] [Related]  

  • 39. StatBite: Key findings from the "Impact on clinical research of European legislation" report.
    J Natl Cancer Inst; 2010 Mar; 102(5):293. PubMed ID: 20173122
    [No Abstract]   [Full Text] [Related]  

  • 40. Gray marketing of pharmaceuticals.
    Chaudhry PE; Walsh MG
    J Health Care Mark; 1995; 15(3):18-22. PubMed ID: 10172516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.